FDA.reportPublic FDA data

Azopt 10 MG/ML Ophthalmic Suspension

RxCUI
213272
RxNorm name
Azopt 10 MG/ML Ophthalmic Suspension
Display name
Azopt 10 MG/ML Ophthalmic Suspension
Full name
Azopt 10 MG/ML Ophthalmic Suspension
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:38:46

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
AzoptBRINZOLAMIDESandoz Inc0afb6589-51ba-432c-aed1-20a12d5d34552023-11-24Warnings, Adverse reactionsExact identifier
rxcui: 213272

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
0afb6589-51ba-432c-aed1-20a12d5d3455Azopt 1 % Ophthalmic Suspension [PSN] · brinzolamide 10 MG/ML Ophthalmic Suspension [Azopt] [SBD] · Azopt 1 % Ophthalmic Suspension [SY] · Azopt 10 MG/ML Ophthalmic Suspension [SY]41These highlights do not include all the information needed to use AZOPT safely and effectively. See full prescribing information for AZOPT. AZOPT ® (brinzolamide ophthalmic suspension) 1%, for topical ophthalmic use Initial U.S. Approval: 199820231124